Nov 13 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2024 Sep 30, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.46 5.53 12.65
(-1.3 pct) (-2.2 pct) (+2.6 pct)
Operating loss 36 mln loss 464 mln 410 mln
Recurring loss 22 mln loss 463 mln 400 mln
Net loss 15 mln loss 345 mln 400 mln
EPS loss 4.13 yen loss 91.33 yen 105.77 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T